Ali Elrazi A, Alamin Mohammed A, Abu-Tineh Mohammad, Ahmed Khalid, Alshurafa Awni, Rozi Waail, Yassin Mohamed A
Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Hematology, Hamad Medical Corporation, Doha, QAT.
Cureus. 2022 May 21;14(5):e25196. doi: 10.7759/cureus.25196. eCollection 2022 May.
Coronavirus disease 2019 (COVID-19) is a respiratory viral illness caused by coronavirus 2 (SARS-CoV-2). The disease often presents with non-specific symptoms, including fever, and fatigue, usually associated with respiratory symptoms (eg., cough) and other systemic involvement. The primary strategy to prevent transmission and reduce the disease severity of the SARS-CoV-2 infection is through vaccination. However, the virus had shown significant changes and mutations that resulted in the emergence of different strains. Each strain varies in its virulence, disease severity, and the body's immune system response. Previous reports showed that the Omicron variant causes mild disease. Little is known about the effect of Omicron in patients with acute leukemia. We present three patients with acute leukemia who had an infection with the Omicron variant of the SARS-CoV-2 virus.
2019冠状病毒病(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的呼吸道病毒性疾病。该病通常表现为非特异性症状,包括发热和疲劳,通常伴有呼吸道症状(如咳嗽)和其他全身受累症状。预防SARS-CoV-2感染传播和降低疾病严重程度的主要策略是接种疫苗。然而,该病毒已出现显著变化和突变,导致不同毒株的出现。每个毒株在毒力、疾病严重程度和人体免疫系统反应方面各不相同。先前的报告显示,奥密克戎变种导致的疾病症状较轻。关于奥密克戎对急性白血病患者的影响知之甚少。我们报告了3例感染了SARS-CoV-2病毒奥密克戎变种的急性白血病患者。